Patent · US Active

Opsin-binding ligands, compositions and methods of use

US9562022B2 · kind B2 · utility

2Cited by
15References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 2010
Grant dateFeb 7, 2017
Priority date
Expiry dateJul 6, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/16
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds and compositions of said compounds along with methods of use of compounds are disclosed for treating ophthalmic conditions related to mislocalization of opsin proteins, the misfolding of mutant opsin proteins and the production of toxic visual cycle products that accumulate in the eye. Compounds and compositions useful in the these methods, either alone or in combination with other therapeutic agents, are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.